SUMMARY A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer side effects than traditional vaccines The Unmet Need: Targeted and durable immune modulation while minimizing systemic toxicity… Read More
SUMMARY Next-generation mRNA vaccine platform uses a lipid-polymer hybrid nanoparticle to boost stability, immune cell uptake, and T cell responses, leading to stronger and longer-lasting protection against viruses and cancer while maintaining strong antibody responses The Unmet Need: Intracellular delivery of mRNA… Read More
SUMMARY Phosphorodiamidate morpholino oligomer (PMO)-based RNA-degrading chimeras reduce α-synuclein protein by degrading its messenger RNA preventing protein aggregation and propagation associated with neurodegenerative diseases. The Unmet Need: More potent and selective therapeutic strategies for neurodegenerative α-synucleinopathies Neurodegenerative diseases such… Read More
SUMMARY Novel antibodies to rapidly and safely expand γδ T cells enabling large-scale production for cancer immunotherapies like γδ CAR-T cells, and potentially boosting these cells directly in patients The Unmet Need: Efficient large-scale expansion of γδ T cells with enhanced… Read More
SUMMARY A chemical process that enables reversible, covalent RNA modification-highly selective for uridine enabling diverse functional group attachment, facilitating nucleic acid labeling The Unmet Need: Reversible labeling of native RNA in a sequence-independent and membrane-selective manner … Read More
SUMMARY The Unmet Need: Methods for efficient, reversible integration and excision of large DNA Genome engineering is a rapidly advancing field with immense potential for synthetic biology and gene therapy. The ability to precisely modify DNA sequences within living cells is crucial… Read More
SUMMARY Engineered tRNAs with altered anticodons and chemical modifications deliver the correct amino acid at mutated codons to restore protein function in genetic diseases or induce lethal mistranslation in cancer cells, supported by tissue-specific expression systems. Unmet Need: Existing treatments have largely focused… Read More
SUMMARY Versatile cutaneous gene therapy platform through skin transplants to stably deliver GLP-1 and other protein factors to treat metabolic disorders The Unmet Need: Long-lasting, safe, and effective gene therapy treatments for metabolic disorders The field of metabolic disease treatment has long been challenged by the need for precise,… Read More
SUMMARY The field of oncological diagnostics and therapeutics has long sought methods to refine treatment approaches for aggressive cancers. In conditions such as advanced high-grade ovarian cancer, there is a critical need for techniques that can accurately predict therapeutic responses and guide personalized treatment decisions. This is driven by the… Read More
SUMMARY A breakthrough method to systematically select for optimal small guide RNAs using an unbiased approach for improved accuracy and efficiency of all systems of site-directed RNA editing. The Unmet Need: In vitro assays that reliably predict guide RNA efficiency and specificity before in… Read More
SUMMARY Innovative therapeutic strategy leveraging commensal microbiota, specifically by oral administration of Bifidobacterium, to enhance anti-tumor immunity, potentially improving cancer treatment when combined with checkpoint inhibitors Unmet Need: Only 20-40% of patients respond to immunotherapy while a majority… Read More
SUMMARY Synaptic transmission and plasticity are fundamental to neuronal functions, and alterations of synaptic protein expression are direct causes of autism, intellectual disability (ID), and epilepsy. De novo loss-of-function (LoF) mutations in SYNGAP1, encoding the synaptic Ras GTPase-activating protein, are among the most prevalent causes of ID and autism spectrum… Read More